Printer Friendly
The Free Library
6,672,050 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Biotechnology industries topic

Subtopics (169)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post. Nov 6, 2009 644
Spectrum Pharmaceuticals Announces Date for Third Quarter 2009 Corporate Update and Pipeline Review Conference Call. Nov 6, 2009 474
ABRAXANE[R] Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma. Nov 5, 2009 686
Complete Genomics Publishes in Science on Low-Cost Sequencing of Three Human Genomes Using Its Proprietary Sequencing Platform. Nov 5, 2009 460
Having swallowed up Schering, Merck hungry to grow more. Nov 5, 2009 639
ArQule Announces Third Quarter Fiscal 2009 Results. Financial report Nov 5, 2009 1957
Compugen Announces Preeclampsia Biomarker Collaboration. Nov 5, 2009 1050
Rosetta Genomics Strengthens MicroRNA Intellectual Property Position with Receipt of Additional Patent. Nov 5, 2009 1000
Abraxis BioScience Reports 2009 Third Quarter Financial Results. Financial report Nov 5, 2009 2427
Illumina Announces Scale-Up of Genome Analyzers at The Broad Institute. Nov 5, 2009 541
MABCURE N.V. Signs Research Agreement With AZ Sint Lucas Hospital, Brugge, Belgium, to Conduct Preclinical Research on its Monoclonal Antibodies (Mabs) against Different Cancers. Nov 4, 2009 569
Alkermes' Corporate Presentation to be Webcast at the Credit Suisse Healthcare Conference. Conference news Nov 4, 2009 147
Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference. Conference news Nov 4, 2009 800
CEO of Vivakor, Inc. (OTCBB: VIVK) to Conduct Exclusive Webcast Interview with The Green Baron Report; New "Stock Pick" Coverage Initiated. Report Nov 4, 2009 528
TRADE NEWS: Agilent Technologies' Next-Generation-Sequencing Human Exome Target Enrichment Portfolio Now Available for SOLiD[TM]. Nov 3, 2009 469
Viriathus Research Issues an Update Report for Viralytics Limited. Report Nov 3, 2009 373
Advanced Cell Technology Announces Upcoming Milestones at BIO Europe 2009. Nov 3, 2009 556
Webinars for Reporters: Pacific Rim Summit to Host Forums on Algae, Cellulosic Biofuels and Renewable Chemicals. Nov 3, 2009 157
Concert Pharmaceuticals to Participate on a Private Company Panel at the Merriman Curhan Ford 6th Annual Investor Summit. Nov 3, 2009 196
CombinatoRx Reports Financial Results for the Third Quarter 2009. Financial report Nov 3, 2009 1678
ZEVALIN[R] Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) Methodology. Nov 3, 2009 859
NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing Spiegelmer[R] NOX-A12. Nov 2, 2009 736
Pulmatrix Receives $2.2 Million from NIH/NIAID to Develop Novel Inhaled Influenza Therapeutics. Nov 2, 2009 858
Pulmatrix Closes $30.2 Million in Series B Financing. Nov 2, 2009 620
Avila Presents Data on Its Novel, Orally-Available Protease Inhibitor, AVL-181, Demonstrating Viral Clearance of Hepatitis C Virus in Preclinical Models. Nov 2, 2009 713
Ligand Updates License Agreement with Exelixis. Nov 2, 2009 537
ACADIA Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 9, 2009. Financial report Nov 2, 2009 319
EnzymeRx Launches Clinical Study of Uricase-PEG 20. Clinical report Nov 2, 2009 413
Institute for Systems Biology to Work With Complete Genomics to Conduct Large-Scale Huntington's Disease Study. Nov 2, 2009 627
Juvaris BioTherapeutics Initiates Phase 2 Study of Influenza Vaccine Adjuvant in Elderly Population. Nov 2, 2009 594
Roche Applied Science Announces CGX Arrays Designed by Signature Genomics for Microarray-based Cytogenetic Analysis. Nov 2, 2009 632
China Kangtai Cactus Biotech Signs Cooperative Agreement To Produce Patented Cactus-based "Green" Animal Feed. Nov 2, 2009 612
Bio-Path Holdings, Inc. Operations Update. Nov 2, 2009 327
Medicilon/MPI Preclinical Research-Shanghai Receives AAALAC Certification. Nov 2, 2009 391
Germany : German biotech raises $53 mln for Alzheimer's work. Nov 2, 2009 140
France : Avesthagen forms JV with French co-operative group. Nov 2, 2009 191
United states : Industry group launches AZBioLink. Nov 2, 2009 434
United States : Human Genome lupus drug succeeds in BLISS-76 trial. Nov 2, 2009 390
Intellectual property policy reform; fostering innovation and development. Book review Nov 1, 2009 182
Rhetorical aspects of discourse in present-day society. Book review Nov 1, 2009 172
United States : Geron hopes to restart stem-cell study in 2010. Oct 31, 2009 144
Rosetta Genomics to Present at Scientific Conference; Provides Update on Colon Cancer Diagnostic Program. Oct 30, 2009 642
ERYtech Pharma Reinforces its Supervisory Board and its Scientific Board. Oct 30, 2009 725
United States : Advaxis Receives IRB Approval For Cervical Dysplasia Trial Of ADXS11-001. Oct 30, 2009 355
United States : Human Genome Sciences declares financial results for third quarter 2009; reports increased revenue growth. Financial report Oct 30, 2009 501
United States: Framingham wastewater collection nets $7.7M from MLSC. Oct 30, 2009 211
United States: $7.7M grant OK d for Framingham project. Oct 30, 2009 364
Switzerland : Novartis says EU approves inflammatory disease drug. Oct 29, 2009 133
France : Sanofi, Micromet seal early-stage cancer drug deal. Oct 29, 2009 126
United States : Sangamo BioSciences awarded a grant to develop zinc finger nuclease-based stem cell therapy for AIDS. Oct 29, 2009 470
Webinar for Reporters: Commercializing Renewable Chemicals. Oct 29, 2009 190
ImmunoGen, Inc. Reports First Quarter Fiscal Year 2010 Financial Results. Oct 29, 2009 1985
Celera Licenses Lung Cancer Intellectual Property from Medical Therapies. Oct 29, 2009 943
Human Genome Sciences Announces Third Quarter 2009 Financial Results and Key Developments. Financial report Oct 29, 2009 1970
Exelixis Announces Third Quarter 2009 Financial Results. Financial report Oct 29, 2009 1430
China Bio-pharmaceutical Summit 2009 to be Organized by CBI China. Oct 29, 2009 300
Xenomics, Inc. Files Suit against Sequenom, Inc. for Fraud. Oct 29, 2009 433
ArQule, Inc. to Report Third Quarter 2009 Financial Results on Thursday, November 5, 2009. Oct 29, 2009 298
Advaxis CEO Thomas A. Moore to Present at the 8th Annual BIO Investor Forum. Oct 29, 2009 399
X-FAB to Moderate First-Ever Panel at 7th Annual SOC International Conference to Explore Interrelationships Between Silicon and Biotechnology. Conference news Oct 28, 2009 318
Nabriva Therapeutics Raises Euro 15 Million (USD 22 Million). Oct 28, 2009 258
Ardea Biosciences to Present at Three Upcoming Investor Conferences. Conference news Oct 28, 2009 441
Advaxis Receives IRB Approval for Cervical Dysplasia Trial Of ADXS11-001. Oct 28, 2009 698
Advaxis Closes Second Company-Run Debt Financing. Oct 28, 2009 526
United States : Developing Countries Sign up for Pharmacogenomics for Every Nation Initiative Using the Affymetrix DMET Plus Panel. Oct 28, 2009 366
United States : Texas Announces $3 Million ETF Investment in Patton Surgical Corp. Oct 28, 2009 319
United States: Cash infusion could push Framingham water, sewer project forward. Oct 28, 2009 258
Telormedix Appoints Johanna Holldack as CEO. Oct 27, 2009 575
ImmunoGen, Inc. Announces Webcast of Presentation at the Oppenheimer 20th Annual Healthcare Conference. Conference news Oct 27, 2009 223
Compugen Reports Third Quarter 2009 Financial Results. Financial report Oct 27, 2009 1088
PolyMedix Completes Successful Phase 1B Clinical Study of Heparin Antagonist PMX-60056. Oct 27, 2009 1524
Developing Countries Sign up for Pharmacogenomics for Every Nation Initiative Using the Affymetrix DMET[TM] Plus Panel. Oct 27, 2009 754
ImmunoCellular Therapeutics Presents Data from Phase I Trial of ICT-107 Demonstrating Significant Increase in Tumor-Free Progression in Patients with Brain Cancer. Oct 27, 2009 1127
Webinar for Reporters: Meeting the Challenges of Commercializing Cellulosic Ethanol. Oct 27, 2009 190
Glaxo lifted after US approves drug; NEWS IN BRIEF. Oct 27, 2009 83
Spectrum Pharmaceuticals to Present at the 2009 BIOCOM Investor Conference. Conference news Oct 26, 2009 484
ImmunoCellular Therapeutics to Present Today Data From Phase I Clinical Trial of ICT-107 at Annual Meeting of Congress of Neurological Surgeons. Oct 26, 2009 747
Halsa Pharmaceuticals Announces ZAG Demonstrates Weight Loss, Rise in Temperature and Reduction of Diabetes Symptoms in Preclinical Studies at Obesity 2009 Annual Scientific Meeting. Oct 26, 2009 770
Lifeline Biotechnologies Reports on FDA Filing Status. Oct 26, 2009 411
Bio-Clean International, Inc. Remains in Negotiations to Sell Subsidiary. Oct 26, 2009 333
Poland : Pulmo BioTech signs agreement with Biotechnology Consulting Poland for commercialization of PulmoBind. Oct 26, 2009 263
United States : European panel reviewing infections linked to Tysabri. Oct 26, 2009 273
United States : IBM Wins Tiens IT Infrastructure Deal. Oct 26, 2009 304
DuBiotech partners with Swiss group. Oct 25, 2009 350
United States : Potentia Pharmaceuticals and Alcon Research sign license and purchase option agreements. Oct 24, 2009 415
United States : Pulmo BioTech signs agreement with Biotechnology Consulting Poland for commercialization of PulmoBind. Oct 24, 2009 263
United States : Biotechnology - Proposal to Place Biomass, Biofuels Under CO2 Emission Cap is Based on Flawed Logic, BIO Says. Oct 24, 2009 398
United States: Proposal to Place Biomass, Biofuels Under CO2 Emission Cap is Based on Flawed Logic, BIO Says. Oct 24, 2009 360
India: Tiens Group Selects IBM to Provide Infrastructure for Technology Park. Oct 23, 2009 271
Biotechs weigh options as IPO market hints at rebound: virtual, low-overhead business model offers promise for firms. Chambers, Heather Oct 19, 2009 652
Illumina fires back after life technologies sues. Chambers, Heather Oct 19, 2009 199
Out with the new: patent rules changes to benefit life sciences. Chambers, Heather Oct 19, 2009 425
With cash on hand growing short, Transdel seeks a partner: Lo Jolla firm has burned through $13.2 million pursuing lead drug candidate. Chambers, Heather Oct 12, 2009 614
Sequenom's woes extend to SEC, FBI, U.S. attorney's office. Chambers, Heather Oct 12, 2009 347
State grant powers up Menon's biowaste-to-biofuels technology: DoD contract also spurs firm's development of plant-based jet fuel. Randolph, Ned Oct 12, 2009 736
Amanda Clardy, chief marketing officer of Life Technologies, was named the 2009 San Diego Magazine Woman of the Year. Glazer, Joyce Brief article Oct 12, 2009 78
Green growth: Best in Green Solutions LLC. Brief article Oct 5, 2009 36
Biotechnology companies in New Hampshire. Oct 1, 2009 49
Vital Therapies initiates liver stabilization trial. Oct 1, 2009 181
Company index. Sep 22, 2009 159

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles